Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.52363 | 21 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.51393 | 22 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.5096 | 22 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.46131 | 22 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.45714 | 21 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.56297 | 21 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.67236 | 27 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.50198 | 22 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.47943 | 21 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.49853 | 22 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.49804 | 22 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.48478 | 22 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.50539 | 21 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.49883 | 21 |